European Psychiatry: Volume 17 - Issue S1

European Psychiatry

Only show content I have access to (961)

Over 3 years (961)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Volume 17 - Issue S1 - May 2002

P01. Antidepressants

Posters, Sunday, 5 May 2002

Placebo-controlled efficacy comparison of escitalopram and citalopram

Escitalopram prevents relapse of depressive episodes

Age specificity in the psychopharmacotherapy of endogenous depressions in adolescence

Glucocorticoid Receptor-mRNA levels are regulated in human blood cells by different types of antidepressants

Duloxetine 60 mg QD is efficacious in the treatment of depression

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

Olanzapine-fluoxetine combination in treatment-resistant depression

Antidepressants of the different chemical groups: clinical and neurophysiological correlations in treating depression

P02. Antipsychotics

Posters, Sunday, 5 May 2002

Coadministration of clozapine and amisulpride in psychotic patients

Characteristics of acute schizophrenic patients on atypical antipsychotics

Cognitive function in stable outpatients switched to ziprasidone

Ziprasidone vs olanzapine for cognitive function in schizophrenia

Health status indices in stable outpatients switched to ziprasidone

Therapeutic response in stable outpatients switched to ziprasidone

Ziprasidone vs haloperidol for IM/oral therapy of acute schizophrenia

The outpatient treatment with olanzapine of a 24-year-old male patient suffering from acute psychosis

No weight gain among demented patients after 1 year of risperidone

Ziprasidone’s long-term efficacy and tolerability in schizophrenia

Ziprasidone vs olanzapine in schizophrenia: a double-blind trial

Recent weight gain and cost of acute service use in schizophrenia

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Volume 17 - Issue S1 - May 2002

P01. Antidepressants

Posters, Sunday, 5 May 2002

P02. Antipsychotics

Posters, Sunday, 5 May 2002